Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel

Gastroenterology

Volumn 119, Issue 5, 2000, Pages 1219-1227

  Ahlquist, David A ^a   Skoletsky, Joel E ^b   Boynton, Kevin A ^b   Harrington, Jonathan J ^a   Mahoney, Douglas W ^a   Pierceall, William E ^b   Thibodeau, Stephen N ^a   Shuber, Anthony P ^b  

^a MAYO CLINIC   (United States)

^b Exact Sciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; CHEMISTRY; COLON TUMOR; FEASIBILITY STUDY; FECES; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; RECTUM TUMOR; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DNA; DNA, NEOPLASM; FEASIBILITY STUDIES; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RECTAL NEOPLASMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 0034322371     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.19580     Document Type: Article

References (49)

1. Landis SH, Murray T, Beiden S, Wingo PA. Cancer statistics, 1998. ÇA Cancer J Clin 1998;48:6-29.
2. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993:328:1365-1371.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult blood test. Lancet 1996:348:1467-1471.
5. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993:269:1262-1267.
6. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer: the impact of serendipity. JAMA 1990:263:76-78.
7. Simon JB. Fecal occult blood testing: clinical value and limitations. Gastroenterologist 1998;6:66-78.
8. Frank JW. Occult blood screening for colorectal cancer: the yield and costs. Am J Prev Med 1985;l:18-24.
9. Ahlquist DA. Fecal occult blood testing for colorectal cancer: can we afford to do this? Gastroenterol Clin North Am 1997;26: 41-55.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990:61:759-767.
11. Boland CR, Sato J, Saito K, Carethers JM, Marra G, Laghi L, Chauhan DP. Genetic instability and chromosomal aberrations in colorectal cancer: a review of current models. Cancer Detect Prev 1998;22:377-382.
12. Ahlquist DA, Gilbert JA. Stool markers for colorectal cancer screening: future considerations. Dig Dis 1996;14:132-144.
13. Poinar HN, Hofreiter M, Spaulding WG, Martin PS, Stankiewicz A, Bland H, Evershed RP, Possnert G, Paabo S. Molecular coproscopy: dung and diet of the extinct ground sloth Notheriops shastensis. Science 1998;281:402-406.
14. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256:102-105.
15. Smith-Ravin J, England J, Talbot 1C, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995;36:81-86.
16. Nollau P, Moser C, Weinland G, Wagener C. Detection of K-ras mutations in stools of patients with colorectal cancer by mutantenriched PCR. Int J Cancer 1996;66:332-336.
17. Villa E, Dugani A, Rebecchi AM, Vignoli A, Grottola A, Buttafoco P, Losi L, Perini M, Trande P, Merighi A, Lerose R, Manenti F. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology 1996;110:1346-1353.
18. Hasegawa Y, Takeda S, Ichii S, Kaizumi K, Maruyama M, Fujii A, Ohta H, Nakajima T, Okuda M, Baba S, Nakamura Y. Detection of K-ras mutations in DMAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA). Oncogene 1995;10:1441-1445.
19. Ratto C, Flamini G, Sofo L, Nucera P, Ippoliti M, Curigliano G, Ferretti G, Sgambato A, Merico M, Doglietto GB, Cittandi A, Crucitti F. Detection of oncogene mutation from neoplastic coIonic cells exfoliated in feces. Dis Colon Rectum 1996:39:12381244.
20. Eguchi S, Kohara N, Komuta K, Kanematsu T. Mutations of the p53 gene in stool of patients with resectable colorectal cancer. Cancer 1996;77:1707-1710.
21. Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993:34:289-292.
22. Samowitz WS, Slattery ML, Potter JD, Leppert MF. BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphins. Am J Pathol 1999:154:1637-1641.
23. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997:57:300-303.
24. Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988:108:609-612.
25. Syvanen AC, Aalto-Setala K, Harju L, Kontula K, Soderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990:8:684-692.
26. Soussi T. p53 mutation in colorectal cancer. Retrieved in revised version from World Wide Web 1999. http://perso.curie.fr/Thierry. Soussi/p53_mutation_in_colon.htr.
27. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisenger AC, Leppert M, Natasmura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal tumor development. N Engl J Med 1988:319:525-532.
28. Soussi T. Frequency of APC mutations. Retrieved in revised version from World Wide Web 1999. http://perso.curie.fr/Thierry. Soussi/APC.htn.
29. Aaltonen LA, Peltomaki P, Leach FS, Siltonen P, Pylkkonen L, Mecklin LP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson G, Kinzler KW, Vogelstein B, de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260: 812-816.
30. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart U, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels W, Farr GH, O'Connell MJ. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principle involvement of hMLHl. Cancer Res 1998;58:1713-1718.
31. Wilde J, Eiden J, Yolken R. Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions. J Clin Microbiol 1990;28:1300-1307.
32. Tsujitani S, Shirai H, Tatebe S, Sugamura K, Ohfugi S, Gomyo Y, Malta M, Ito H, Kaibara N. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer 1996; 77(suppl):1711-1716.
33. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibitation of apoptosis during development of colorectal cancer. Cancer Res 1995;55: 1811-1816.
34. Ahlquist DA, Harrington JJ, Burgart U, Roche PC. Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 2000;31:51-57.
35. Pötten CS, Allen TD. Ultrastructure of cell loss in intestinal mucosa. J Ultrastructure Res 1977;60:272-277.
36. Stratter J, Wedding U, Barth TFE, Koretz K, Elsing C, Moller P. Rapid onset of apoptosis in vitro follows disruption of l-integrin/matrix interactions in human colonie crypt cells. Gastroenterology 1996;110:1776-1784.
37. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-557.
38. Sen S. Programmed cell death: concept, mechanism and control. Biol Rev 1992;67:287-319.
39. Ahlquist DA, Cameron AJ, Jett J, Pearson RK, de Groen PC, Edell ES, Huyber ML, Devens ME, Shuber A. Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool (abstr). Gastroenterology 2000;118:A855.
40. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994:54:35683573.
41. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995;108:434-440.
42. Zhu P, Keohavong P, Finkelstein SD, Swalsky P, Bakker A, Weissfeld J, Srivastava S, Whiteside TL. K-ras gene mutation in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res 1997;57:2485-2492.
43. Samowitz WS, Slattery ML, Potter JD, Leppert MF. Bat-26 and Bat-40 instability in colorectal adenomas and carcinomas and germline polymorphins. Am J Pathol 1999:154:1637-1641.
44. Pyatt R, Chadwick RB, Johnson CK, Adebamawo C, de la Chapelle A, Prior TW. Polymorphic variation at the Bat-25 and Bat-26 loci in individuals of African origin. Am J Pathol 1999;155:349-353.
45. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
46. Samowitz WS, Slattery ML. Microsatellite instability in colorectal adenomas. Gastroenterology 1997:112:1515-1519.
47. Young J, Leggett B, Gustafson C, Ward M, Searle J, Thomas L, Buttenshaw R, Chenevix-Trench G. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutât 1993; 2:351-354.
48. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, liono H, Fukayama M, Koike M, Mori T, Sakuraba H, Fukunari H, Iwama T, Miyaki M. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and nonfamilial adenomatous polyposis patients. Cancer Res 1992;52:39653971.
49. Service RF. Microchip .srrays put DNA on the spot. Science 1998; 282:396-401.